Biopharmaceutical Third Party Logistics Market Size by Specimen, Service Type, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2030
Overview
Biopharmaceutical Third Party Logistics Market size was valued at US$ 3.52 Mn in 2023 and the total revenue is expected to grow at 5.7% through 2024 to 2030, reaching nearly US$ 5.18 Mn in the forecast period.
Biopharmaceutical Third Party Logistics Market Overview:
Biopharmaceutical Third Party Logistics is a service that offers import and export of biopharmaceutical ingredients by the pharmaceutical companies by the involvement of third-party logistics. The various functions of third-party logistics are inventory management, warehousing, and fulfillment to a third-party business authority. This process involves on the contract basis between two business operations.
To know about the Research Methodology :- Request Free Sample Report
Biopharmaceutical Third Party Logistics Market Dynamics:
The Biopharmaceutical Third Party Logistics Market is predictable to grow with a CAGR of 5.7% during the forecast period. The growth of the market is attributed to the building of a strong network in sales with new launches around the world. Moreover, the launching of biosimilar drugs with growing chronic diseases is likely to fuel the market growth in the forecast period. Biosimilar drugs are economic and due to this factor, they are creating dominance in the market.
Technological innovation in warehousing like temperature management, mobile cloud solutions, data mining, real-time monitoring, and warehouse robotics is the key reason to boost the market growth. Further, these advancements are innovated to decrease human errors, reduce damages and complexity during transportation, and maintain the quality of goods like factory-made. Further, warehousing robotics is widely preferred as it reduces the labor cost while increasing warehouse throughput. This factor is increasing the adoption of robotics in warehousing due to reducing operational costs.
In 2019, Amazon manufactured 100,000 robotic systems together with 800 Pegasus and Xanthus robotics systems to fulfill around 25 centers around the US. Robotics monitoring is greatly influencing the market as pharmaceutical ingredients are temperature sensitive and require continuous monitoring during transit.
Moreover, companies like DHL launched a new Android and IOS app named LifeTrack which helps in monitoring the cold chain tracking platform for healthcare and pharmaceutical ingredient shipment. The app has the function to send the alarm to the shipper during the complexity. And this factor is likely to boost the Biopharmaceutical Third Party Logistics Market during the forecast period.
Biopharmaceutical Third Party Logistics Market Segment Analysis:
Non-cold chain is dominating the Supply Chain segment of Biopharmaceutical Third Party Logistics Market:
The non-cold chain segment is gaining more attention as compared to the cold chain segment and has accounted for the largest revenue share of 81.3% in 2023 in the Biopharmaceutical Third Party Logistics Market. The factors attributing to the growth of the market are the large-scale distribution of medicines and vaccines, high visibility, low-cost optimization, higher returns with lower risk, and these factors also help in building a strong logistic network. Further, the non-cold chain supply chain does not require continuous monitoring of temperatures like biologics and this factor is likely to fuel the growth of the market. Also, the non-cold supply chain is the most preferred mode of transit.
The Cold Chain segment is growing at a significant pace in the forecast period with a CAGR of 8.9%. Biologics are greatly influencing the cold chain segment as they have gained more attention in the market. Further, the cold chain supply chain is also used for the transportation of blood products, marker testing, cellular therapies, organ transportation, vaccines, and regenerative medicines.
The warehousing and Storage segment is considered to supplement the growth of the Global Biopharmaceutical Third Party Logistics Market.
The warehousing and storage segment is dominating the Biopharmaceutical Third Party Logistics Market and accounted for 47.2% in 2023. The warehousing and storage segment is greatly influenced by the pharmaceutical and healthcare industries. To reduce the overall cost of end-product life science companies binding with third party logistics. Moreover, due to excess demand, the transit companies have increased the value-added services like warehousing and packaging to reduce the complexity and rush. Further, the companies have installed the barcode scanners and robots for the pic and drop facility for loading and unloading of the products.
The packaging facility is the main department of warehousing the storage segment as it requires high-quality containers that are damage resistant with waterproof coating as per the regulatory standards. And these factors are further fueling the demand of the warehouse and storage segment of the Global Biopharmaceutical Third Party Logistics Market.
Biopharmaceutical Third Party Logistics Market Regional Insights:
North America is dominating the global biopharmaceutical third party logistics market, with the largest market share of 43.5% in the forecast period. The growth is dominated by the increasing import and export of pharmaceutical ingredients, drugs, biologics, vaccines, and other. Furthermore, the investment in the healthcare sector by the government and the private organization together with technological advancement in the transport industry are supplementing the growth of the market in favorable aspects.
Asia Pacific has estimated a substantial market share of USD 18200 million in 2020 and is likely to grow with a CAGR of 8.1% during the forecast period. The occurrence of chronic diseases like diabetes, obesity, cardiovascular diseases are grabbing more attention in the region hence this factor is creating more demand for medicine and drugs in a growing population. In addition, high technologies and advanced services with the growing economic condition of the region are the factors likely to supplement the growth of the market during the forecast period.
The objective of the report is to present a comprehensive analysis of the Global Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.
Biopharmaceutical Third Party Logistics Market Scope: Inquire before buying
| Biopharmaceutical Third Party Logistics Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 3.52 Mn. |
| Forecast Period 2024 to 2030 CAGR: | 5.7% | Market Size in 2030: | US $ 5.18 Mn. |
| Segments Covered: | by Specimen | Cold Chain Non-cold Chain |
|
| by Service Type | Air Freight Sea Freight Overland Warehousing and Storage Others |
||
Biopharmaceutical Third Party Logistics Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Biopharmaceutical Third Party Logistics Market, Key Players
1. FedEx.
2. DHL International GmbH
3. SF Express
4. United Parcel Service of America, Inc.
5. AmerisourceBergen Corporation
6. DB Schenker
7. KUEHNE + NAGEL
8. Kerry Logistics Network Limited
9. Agility
10. McKesson Corporation
11. Nippon Express
12. C.H. Robinson Worldwide
13. Sinotrans
14. CEVA Logistics
Frequently Asked Questions:
1. Which region has the largest share in Global Biopharmaceutical Third Party Logistics Market?
Ans: North America region held the highest share in 2023.
2. What is the growth rate of Global Biopharmaceutical Third Party Logistics Market?
Ans: The Global Biopharmaceutical Third Party Logistics Market is growing at a CAGR of 5.7% during forecasting period 2024-2030.
3. What is scope of the Global Biopharmaceutical Third Party Logistics Market report?
Ans: Global Biopharmaceutical Third Party Logistics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Biopharmaceutical Third Party Logistics Market?
Ans: The important key players in the Global Biopharmaceutical Third Party Logistics Market are - FedEx.,DHL International GmbH,SF Express,United Parcel Service of America, Inc.,AmerisourceBergen Corporation,DB Schenker,KUEHNE + NAGEL,Kerry Logistics Network Limited,Agility,McKesson Corporation,Nippon Express,C.H. Robinson Worldwide,Sinotrans,CEVA Logistics.
5. What is the study period of this Market?
Ans: The Global Biopharmaceutical Third Party Logistics Market is studied from 2023 to 2030.